Sandor Victor

CIK 00016203685 companiesBOULDER, CO

SEC Profile

Transactions

Companies

Filings

CIK

0001620368

Recent Transactions

50 trades

Disposition to Issuer
Merus N.V.$MRUS
Share Option (right to buy)
2025-12-12−17,000→ 0 total
Disposition to Issuer
Merus N.V.$MRUS
Share Option (right to buy)
2025-12-12−13,193→ 0 total
Disposition to Issuer
Merus N.V.$MRUS
Share Option (right to buy)
2025-12-12−8,631→ 0 total
Disposition to Issuer
Merus N.V.$MRUS
Share Option (right to buy)
2025-12-12−8,844→ 0 total
Disposition to Issuer
Merus N.V.$MRUS
Share Option (right to buy)
2025-12-12−16,604→ 0 total
Disposition to Issuer
Merus N.V.$MRUS
Share Option (right to buy)
2025-12-12−6,120→ 0 total
Disposition to Issuer
Merus N.V.$MRUS
Share Option (right to buy)
2025-12-12−14,414→ 0 total
Award
Prelude Therapeutics Inc$PRLD
Director Stock Option (Right to Buy)
2025-11-05+121,285→ 121,285 total
Award
Kymera Therapeutics, Inc.$KYMR
Stock Option (Right to Buy)
2025-06-25+16,000→ 16,000 total
Tax Payment
ADC Therapeutics SA$ADCT
Common Shares
2025-06-13$3.58/sh−12,600→ 108,286 total
Award
Prelude Therapeutics Inc$PRLD
Director Stock Option (Right to Buy)
2025-06-12+38,000→ 38,000 total
Award
ADC Therapeutics SA$ADCT
Common Shares
2025-06-03+40,000→ 120,886 total
Award
Merus N.V.$MRUS
Share Option (right to buy)
2025-05-22+13,193→ 13,193 total
Award
Kymera Therapeutics, Inc.$KYMR
Stock Option (Right to Buy)
2024-06-18+16,000→ 16,000 total
Sale
ADC Therapeutics SA$ADCT
Common Shares
2024-06-17$2.89/sh−6,995→ 80,886 total
Award
Prelude Therapeutics Inc$PRLD
Director Stock Option (Right to Buy)
2024-06-14+23,500→ 23,500 total
Award
ADC Therapeutics SA$ADCT
Common Shares
2024-06-13+40,000→ 87,881 total
Award
Merus N.V.$MRUS
Share Option (right to buy)
2024-05-07+8,844→ 8,844 total
Award
Prelude Therapeutics Inc$PRLD
Director Stock Option (Right to Buy)
2023-06-16+23,500→ 23,500 total
Award
Kymera Therapeutics, Inc.$KYMR
Stock Option (Right to Buy)
2023-06-15+12,000→ 12,000 total
Award
Merus N.V.$MRUS
Share option (right to buy)
2023-06-08+14,414→ 14,414 total
Award
Kymera Therapeutics, Inc.$KYMR
Stock Option (Right to Buy)
2022-11-03+24,000→ 24,000 total
Award
Prelude Therapeutics Inc$PRLD
Director Stock Option (Right to Buy)
2022-06-17+34,300→ 34,300 total
Award
Merus N.V.$MRUS
Share option (right to buy)
2022-05-31+16,604→ 16,604 total
Award
Prelude Therapeutics Inc$PRLD
Director Stock Option (Right to Buy)
2022-01-03+11,206→ 11,206 total
Award
Prelude Therapeutics Inc$PRLD
Director Stock Option (Right to Buy)
2021-10-13+8,022→ 8,022 total
Award
Prelude Therapeutics Inc$PRLD
Director Stock Option (Right to Buy)
2021-06-18+23,344→ 23,344 total
Award
Merus N.V.$MRUS
Share option (right to buy)
2021-05-28+6,120→ 6,120 total
Award
Prelude Therapeutics Inc$PRLD
Director Stock Option (right to buy)
2020-09-24+3,458→ 3,458 total
Award
Merus N.V.$MRUS
Share Option (right to buy)
2020-06-30+8,631→ 8,631 total
Disposition to Issuer
ARRAY BIOPHARMA INC
Stock Option (Right to Buy)
2019-07-30−87,500→ 0 total
Disposition to Issuer
ARRAY BIOPHARMA INC
Stock Option (Right to Buy)
2019-07-30−289,500→ 0 total
Disposition to Issuer
ARRAY BIOPHARMA INC
Common Stock
2019-07-30$48.00/sh−209,543→ 114,821 total
Disposition to Issuer
ARRAY BIOPHARMA INC
Stock Option (Right to Buy)
2019-07-30−270,828→ 0 total
Disposition to Issuer
ARRAY BIOPHARMA INC
Common Stock
2019-07-30−114,821→ 0 total
Disposition to Issuer
ARRAY BIOPHARMA INC
Stock Option (Right to Buy)
2019-07-30−289,500→ 0 total
Disposition to Issuer
ARRAY BIOPHARMA INC
Stock Option (Right to Buy)
2019-07-30−187,500→ 0 total
Exercise/Conversion
ARRAY BIOPHARMA INC
Stock Option (Right to Buy)
2019-06-04−100,000→ 87,500 total
Sale
ARRAY BIOPHARMA INC
Common Stock
2019-06-04$28.51/sh−100,000→ 209,543 total
Exercise/Conversion
ARRAY BIOPHARMA INC
Common Stock
2019-06-04$7.30/sh+100,000→ 309,543 total
Exercise/Conversion
ARRAY BIOPHARMA INC
Stock Option (Right to Buy)
2019-06-03−36,134→ 0 total
Sale
ARRAY BIOPHARMA INC
Common Stock
2019-06-03$27.58/sh−36,134→ 209,543 total
Exercise/Conversion
ARRAY BIOPHARMA INC
Common Stock
2019-06-03$3.65/sh+36,134→ 245,677 total
Exercise/Conversion
ARRAY BIOPHARMA INC
Common Stock
2019-05-30$3.65/sh+15,728→ 225,271 total
Exercise/Conversion
ARRAY BIOPHARMA INC
Stock Option (Right to Buy)
2019-05-30−15,728→ 36,134 total
Sale
ARRAY BIOPHARMA INC
Common Stock
2019-05-30$27.50/sh−15,728→ 209,543 total
Exercise/Conversion
ARRAY BIOPHARMA INC
Stock Options (Right to buy)
2019-05-28−46,766→ 51,862 total
Sale
ARRAY BIOPHARMA INC
Common Stock
2019-05-28$27.00/sh−74,915→ 209,543 total
Exercise/Conversion
ARRAY BIOPHARMA INC
Common Stock
2019-05-28$3.65/sh+46,766→ 284,458 total
Sale
ARRAY BIOPHARMA INC
Common Stock
2019-05-23$26.50/sh−40,634→ 237,692 total

Sandor Victor

Recent Transactions

Companies

Recent Filings

Address